Brain cancer. A viral link to glioblastoma?
Miller
Greg
G
D000998:Antiviral Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000628:therapy / Q000821:virology*; D019496:Cancer Vaccines / Q000627:therapeutic use; D002472:Cell Transformation, Viral; D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000150:complications / Q000628:therapy / Q000821:virology*; D015774:Ganciclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D005909:Glioblastoma / Q000628:therapy / Q000821:virology*; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D000077562:Valganciclovir; D014764:Viral Proteins / Q000276:immunology / Q000378:metabolism; D014765:Viral Vaccines / Q000627:therapeutic use
D000998:Antiviral Agents; D019496:Cancer Vaccines; D014764:Viral Proteins; D014765:Viral Vaccines; D000077562:Valganciclovir; D015774:Ganciclovir